SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001576885-23-000036
Filing Date
2023-06-07
Accepted
2023-06-07 17:44:36
Documents
4
Period of Report
2023-06-06

Document Format Files

Seq Description Document Type Size
1 FORM 4 wk-form4_1686174265.html 4  
1 FORM 4 wk-form4_1686174265.xml 4 4676
2 EX-24.1 acumen-section16limitedp.htm EX-24.1 3961
3 acumen-section16limitedp001.jpg GRAPHIC 195024
4 acumen-section16limitedp002.jpg GRAPHIC 36515
  Complete submission text file 0001576885-23-000036.txt   329130
Mailing Address 427 PARK ST. CHARLOTTESVILLE VA 22902
Business Address 427 PARK ST. CHARLOTTESVILLE VA 22902 925-368-8508
Acumen Pharmaceuticals, Inc. (Issuer) CIK: 0001576885 (see all company filings)

IRS No.: 364108129 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address C/O ACUMEN PHARMACEUTICALS, INC. 427 PARK STREET CHARLOTTESVILLE VA 22902
Business Address
Stoppel Laura (Reporting) CIK: 0001865119 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-40551 | Film No.: 231000083